Cure Kids have invested over $19 million in medical research. This research has helped save hundreds of young lives and has improved the quality of life for thousands of children.
Today, we are more committed than ever to help find answers to the many cruel, life-threatening illnesses that devastate the lives of young children and their families. The research funded by Cure Kids has already led directly to several exciting commercial applications such as A2, Nexus 6, and Living Cell Technologies.
The goal of Cure Kids Ventures Limited is to maximise and leverage promising research into collaborative research, venture investment and ultimately commercialisation, which can then be reinvested back into childhood health.
PO Box 105-384, Auckland 1143
Contact: Maxine Simmons, CEO
M: 021 625 635